Objective
VetBioNet seeks to complement and strengthen the present European capacity and competence to meet the challenges of (re)emerging infectious diseases by establishing a comprehensive network of pre-eminent European BSL3 infrastructures, international organisations, and industry partners that is dedicated to advance research on epizootic and zoonotic diseases and to promote technological developments.
To reach this overall objective VetBioNet will:
-Promote and facilitate Transnational Access (TNA) to the infrastructure resources of the network, including BSL3 animal experimental facilities and laboratories, technological platforms, and sample collections.
-Promote technological development by involving private partners in the Integrating Activity of the network and by providing a communication platform for bidirectional exchange with industry stakeholders.
-Enhance the preparedness of the major European BSL3 research infrastructures to accelerate the respond to (re)emerging epizootic and zoonotic threats by sharing capacities beyond the infrastructures.
-Harmonise Best Practices and promote the use of global standards in European BSL3 infrastructures.
-Forge cooperative relationships with non-European BSL3 infrastructures, research institutes, industrial partners, international organisations, and policy makers.
-Ensure high ethical standards and clarify the social impact of VetBioNet research work.
-Develop and implement a Sustainability Plan for the network to continue beyond the five-year term of funding.
-Carry out Joint Research Activities (JRAs) designed to improve the scientific and technological standards of the integrated services provided by the network infrastructures.
The establishment of this network and the realisation of the proposed work programme will help to advance the efficiency of European research on emerging epizootic and zoonotic diseases, which in turn will lead to the development of adequate and robust prevention and control measures.
Fields of science
- medical and health scienceshealth sciencesinfectious diseasesRNA virusesinfluenza
- medical and health sciencesmedical biotechnologycells technologiesstem cells
- medical and health scienceshealth sciencesinfectious diseasesRNA virusescoronaviruses
- natural sciencesearth and related environmental sciencesatmospheric sciencesclimatologyclimatic changesnorth atlantic oscillation
- medical and health scienceshealth sciencespublic healthepidemiologyzoonosis
Keywords
Programme(s)
Funding Scheme
RIA - Research and Innovation actionCoordinator
75007 Paris
France
See on map
Participants (27)
6708 PB Wageningen
See on map
17493 Greifswald-Insel Riems
See on map
GU24 0NF Woking
See on map
SW1P 4DF LONDON
See on map
EH26 0PZ Penicuik
See on map
28006 Madrid
See on map
08140 Caldes De Montbui Barcelona
See on map
3003 Bern
See on map
24100 Pulawy
See on map
Participation ended
AB119DB Aberdeen
See on map
8000 Aarhus C
See on map
94700 Maisons Alfort
See on map
EH8 9YL Edinburgh
See on map
3015 GD Rotterdam
See on map
35020 Legnaro
See on map
NG7 2RD Nottingham
See on map
4 Dublin
See on map
00100 Nairobi
See on map
2601 Acton Act
See on map
00161 Roma
See on map
38124 Braunschweig
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
35578 Wetzlar
See on map
6709 PA Wageningen
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
GU21 7SA Woking
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
AB24 2TZ Aberdeen
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
28037 MADRID
See on map
75013 PARIS
See on map